Aspirin + dipyridamole preferable for stroke prevention

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.265, 2000-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin plus dipyridamole effective in secondary stroke prevention

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Dipyridamole plus aspirin cost effective in stroke prevention

Inpharma, Vol. 1, Iss. 1450, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK: Aspirin, Dipyridamole and Aspirin-Dipyridamole

By Chambers M.

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 577-593

Adis International

Access to resources Recommend Favorite

Aspirin/dipyridamole beats aspirin in recurrent stroke

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 246, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox ® /Asasantin ® ) in France

By Jean-Pierre Marissal Bernard Selke

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 661-670

Adis International

Access to resources Recommend Favorite